8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Cancer & Tumors1,064 citations

Ye W, Wang F, Zhang W, Fang N, Zhao W, Wang J

Bioeffects Seen

Authors not listed · 2016

Share:

Nearly half of lung cancers show genetic patterns that could make them vulnerable to environmental stressors like EMF exposure.

Plain English Summary

Summary written for general audiences

Researchers analyzed genetic mutations in 1,144 lung cancer samples, comparing two main types: adenocarcinoma and squamous cell carcinoma. They discovered new cancer-driving genes and found that nearly half of all lung tumors contained enough genetic changes to potentially respond to immunotherapy treatments.

Why This Matters

While this study focuses on genetic analysis of lung tumors rather than EMF exposure directly, it provides crucial context for understanding how environmental factors might contribute to cancer development. The discovery that 47-53% of lung cancers contain significant genetic alterations suggests these tumors may be particularly vulnerable to additional environmental stressors, including electromagnetic field exposure. The identification of new cancer-driving genes like PPP3CA and DOT1L offers important targets for understanding how EMF exposure might interact with existing genetic vulnerabilities. What makes this research particularly relevant is that it demonstrates how complex genetic pathways can be disrupted in cancer development, potentially making cells more susceptible to the oxidative stress and DNA damage that multiple studies have linked to EMF exposure.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2016). Ye W, Wang F, Zhang W, Fang N, Zhao W, Wang J.
Show BibTeX
@article{ye_w_wang_f_zhang_w_fang_n_zhao_w_wang_j_ce3915,
  author = {Unknown},
  title = {Ye W, Wang F, Zhang W, Fang N, Zhao W, Wang J},
  year = {2016},
  doi = {10.1038/ng.3564},
  
}

Quick Questions About This Study

Scientists examined 1,144 lung cancer tumor samples paired with normal tissue, including 660 adenocarcinomas and 484 squamous cell carcinomas, making this one of the largest genetic studies of lung cancer to date.
Researchers identified several previously unknown cancer-driving genes, including PPP3CA, DOT1L, and FTSJD1 in adenocarcinoma, RASA1 in squamous cell carcinoma, and KLF5, EP300, and CREBBP affecting both cancer types.
The study found that 47% of adenocarcinomas and 53% of squamous cell carcinomas contained at least five predicted neoepitopes, suggesting these tumors might be good candidates for immunotherapy treatment approaches.
No, the research revealed that lung squamous cell carcinomas were genetically more similar to other squamous cancers throughout the body than to lung adenocarcinomas, indicating distinct developmental pathways for different lung cancer types.
Scientists discovered new amplification peaks including MIR21 in adenocarcinoma, MIR205 in squamous cell carcinoma, and MAPK1 in both cancer types, representing areas where genetic material is duplicated abnormally in tumors.